Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Fmr LLC

FMR LLC boosted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 3.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,311,867 shares of the company's stock after purchasing an additional 546,869 shares during the period. FMR LLC owned approximately 14.40% of Surgery Partners worth $590,375,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company's stock worth $223,099,000 after buying an additional 61,400 shares during the period. DekaBank Deutsche Girozentrale increased its holdings in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock valued at $80,000 after buying an additional 1,375 shares during the last quarter. Wesbanco Bank Inc. raised its stake in shares of Surgery Partners by 53.4% in the second quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company's stock worth $936,000 after buying an additional 13,700 shares during the period. SG Americas Securities LLC increased its stake in Surgery Partners by 190.0% in the 2nd quarter. SG Americas Securities LLC now owns 17,276 shares of the company's stock worth $411,000 after buying an additional 11,318 shares in the last quarter. Finally, Raymond James & Associates raised its holdings in Surgery Partners by 6.8% during the second quarter. Raymond James & Associates now owns 68,872 shares of the company's stock valued at $1,638,000 after acquiring an additional 4,370 shares during the period.

Surgery Partners Stock Performance

SGRY stock traded up $0.43 during trading on Friday, reaching $23.84. The company had a trading volume of 882,545 shares, compared to its average volume of 973,728. The company has a market cap of $3.03 billion, a price-to-earnings ratio of -48.94, a price-to-earnings-growth ratio of 19.49 and a beta of 2.76. Surgery Partners, Inc. has a twelve month low of $21.36 and a twelve month high of $36.92. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a 50-day simple moving average of $29.15 and a 200-day simple moving average of $28.24.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. During the same quarter last year, the company posted $0.15 EPS. Surgery Partners's quarterly revenue was up 14.3% compared to the same quarter last year. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. StockNews.com downgraded shares of Surgery Partners from a "hold" rating to a "sell" rating in a report on Wednesday, August 7th. Benchmark reissued a "buy" rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. Macquarie reissued an "outperform" rating and issued a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. KeyCorp initiated coverage on Surgery Partners in a report on Friday, October 11th. They issued a "sector weight" rating on the stock. Finally, Royal Bank of Canada dropped their price objective on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a report on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $38.71.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.